Nature Research, npj Parkinson's Disease, 1(6), 2020
DOI: 10.1038/s41531-020-00140-z
Full text: Download
AbstractThe aim of this study was to assess cerebrospinal fluid (CSF) concentrations of specific amino acids using a high-performance liquid chromatography system in a sample of patients with functional movement disorders (FMDs) and in a sample of controls. CSF levels of glutamate were significantly lower in patients with FMD than in controls. This finding argues in favor of glutamatergic dysfunction in the pathophysiology of FMD.